CR6-25992-15029
4 vaccinations
8 coded responses
26 check-ins
8 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 956 / CA
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Dose 1 — Moderna
-
2021-02-24
Registered in v-safe
-
2021-02-24
Survey response — day 14, dose 1MedDRA: Injection site erythema, Injection site induration, Injection site pruritus, Injection site warmth — Feeling: FairFree text: Didn't sign up before.Approx 11 days after shot my injection site got hot, red, itchy, size of a baseball and hard-size of a almond.Site has remained same except for lighter red and not itchy now.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
-
2021-03-02
Dose 2 — Moderna
-
2021-03-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Chills, Headache · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-04
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-03-05
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Redness, Swelling, Itching · Headache, Fatigue or tirednessAdult check-in
- 2021-03-06
-
2021-03-07
Survey response — days 1–6 daily, dose 2MedDRA: Pre-existing disease — Feeling: Fair · Headache, Fatigue or tiredness, Abdominal painFree text: Due to cancer treatmentsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-08
Survey response — days 1–6 daily, dose 2MedDRA: Neoplasm malignant — Feeling: Fair · Headache, Fatigue or tiredness, Abdominal painFree text: Most likely due to cancerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-09
Survey response — day 7, dose 2MedDRA: Adverse reaction — Feeling: Fair · Headache, Fatigue or tiredness, Abdominal painFree text: Due to cancerMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-23
-
2021-03-30
Survey response — day 28, dose 2MedDRA: Unevaluable event — Feeling: FairFree text: Due to chemo treatments, not covid or vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-06
- 2021-04-13
- 2021-06-01
-
2021-08-18
Dose 3 — Moderna
- 2021-08-31
- 2021-11-17
-
2022-02-17
Survey response — 6 months, dose 3MedDRA: Condition aggravated, Office visit, Pre-existing disease — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: My ovarian cancer returned and am under treatment again. · Healthcare visit (other): OncologistMedDRA releases: 2024-11 · check-in free text available
-
2022-02-17
Report sent to call center — 6 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-02-23
-
2022-04-03
Dose 4 — Moderna
-
2022-04-14
Health check-in — day 7, dose 4Feeling: Fair · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-04-17
- 2022-04-24
- 2022-05-01
- 2022-05-08
-
2022-05-17
Survey response — day 42, dose 4MedDRA: Kidney infection, Nausea, Office visit, Pre-existing disease, Transfusion — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Due to ovarian cancer have had a transfusion, a kidney infection (have a barbaric kidney bag) and nausea. · Healthcare visit (other): OncologistMedDRA releases: 2024-11 · check-in free text available
-
2022-05-17
Report sent to call center — day 42, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-05-18
- 2022-05-18
- 2022-07-03
-
2022-10-02
Survey response — 6 months, dose 4MedDRA: Malignant neoplasm progression, Office visit, Pre-existing disease — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: More cancer tumors through out body, · Healthcare visit (other): Oncologist apptsMedDRA releases: 2024-11 · check-in free text available
-
2022-10-02
Report sent to call center — 6 months, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-10-03
- 2022-10-03
- 2022-10-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Moderna | |
| 2 | 2021-03-02 | Moderna | |
| 3 | 2021-08-18 | Moderna | No |
| 4 | 2022-04-03 | Moderna | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 4 — day 14, dose 1
Symptoms: Didn't sign up before.Approx 11 days after shot my injection site got hot, red, itchy, size of a baseball and hard-size of a almond.Site has remained same except for lighter red and not itchy now.
Release 5 — days 1–6 daily, dose 2
Systemic reaction (other): Due to cancer treatments
Systemic reaction (other): Most likely due to cancer
Release 5 — day 7, dose 2
Systemic reaction (other): Due to cancer
Release 6 — day 28, dose 2
Symptoms: Due to chemo treatments, not covid or vaccine
Release 11 — 6 months, dose 3
Symptoms: My ovarian cancer returned and am under treatment again.
Healthcare visit (other): Oncologist
Release 11 — day 42, dose 4
Symptoms: Due to ovarian cancer have had a transfusion, a kidney infection (have a barbaric kidney bag) and nausea.
Healthcare visit (other): Oncologist
Release 12 — 6 months, dose 4
Symptoms: More cancer tumors through out body,
Healthcare visit (other): Oncologist appts
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Condition aggravated | · | · | ✓ |
| SD | Injection site erythema | ✓ | ✓ | ✓ |
| SD | Injection site induration | ✓ | ✓ | ✓ |
| SD | Injection site pruritus | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Kidney infection | · | · | ✓ |
| SD | Malignant neoplasm progression | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Transfusion | · | · | ✓ |
| SD | Unevaluable event | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Neoplasm malignant | ✓ | ✓ | ✓ |
| SRO | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release